The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Size Is Forecasted For The RNA Targeting Small Molecule Drug Discovery Market By 2030 Based On Its 2026 Value?
The rna targeting small molecule drug discovery market size has seen significant expansion in recent years. It is anticipated to increase from $2.13 billion in 2025 to $2.6 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.3%. The growth observed in previous periods is attributable to the constrained druggability of protein targets, a rising incidence of genetic disorders, developments in rna biology research, an increase in academic-industry collaborations, and the initial successes of rna-based therapeutics.
The rna targeting small molecule drug discovery market is projected to experience significant expansion in the coming years, with its size expected to reach $6.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 23.5%. This growth throughout the forecast period can be attributed to factors such as AI-enabled RNA target identification, increased investment in precision medicine, the broadening of RNA therapeutics pipelines, advancements in RNA delivery technologies, and regulatory support for novel therapeutic modalities. Prominent trends anticipated during this period include AI-driven RNA structure prediction, the expansion of RNA-targeted oncology pipelines, progress in developing RNA-specific small molecule libraries, enhanced RNA binding selectivity and specificity, and the integration of multi-omics approaches in RNA drug discovery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12480&type=smp
Which Growth Drivers Are Expected To Support The RNA Targeting Small Molecule Drug Discovery Market Forward?
The projected expansion of the RNA-targeted small-molecule drug discovery market is anticipated to be driven by the rising incidence of cancer, genetic disorders, and viral infections. Cancer encompasses a range of illnesses defined by the uncontrolled proliferation of cells within the body. Viral infections are conditions resulting from viruses, which are microscopic infectious entities capable of replicating solely within the living cells of organisms. RNA targeting-based drug discovery offers therapeutic solutions for cancer, genetic disorders, and viral infections. This is because these conditions are associated with genes and impaired genetic material, making them amenable to treatment through drugs formulated with RNA targeting-based approaches. For example, a report released in February 2024 by the World Health Organization (WHO), an intergovernmental body located in Switzerland, indicated an estimated 20 million new cancer diagnoses and 9.7 million fatalities worldwide in 2022. Among these, Lung cancer was identified as the most prevalent, accounting for 2.5 million new cases (12.4%). It was succeeded by female breast cancer with 2.3 million cases (11.6%), colorectal cancer at 1.9 million cases (9.6%), prostate cancer registering 1.5 million cases (7.3%), and stomach cancer with 970,000 cases (4.9%). Projections suggest that by 2050, the incidence of new cancer cases will escalate by 77%, surpassing 35 million each year. Consequently, the escalating occurrence of cancer, genetic disorders, and viral infections serves as a key impetus for the expansion of the RNA-targeted small-molecule drug discovery market.
What Are The Major Segment Categories Within The RNA Targeting Small Molecule Drug Discovery Market?
The rna targeting small molecule drug discovery market covered in this report is segmented –
1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
3) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
4) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications
Subsegments:
1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding, Modulation Of mRNA Stability, mRNA Translation Inhibition
2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA, Small Nuclear RNA, Small Nucleolar RNA
3) By MicroRNA (miRNA): miRNA Inhibition, miRNA Mimics, Targeting Specific miRNA Pathways
4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators, Targeting Specific lncRNA Functions, Therapeutic Applications Of lncRNA
What Trends Are Shaping The RNA Targeting Small Molecule Drug Discovery Market Structure?
Major companies operating in the RNA-targeting small-molecule drug discovery market are developing innovative platforms, such as software-as-a-service models, to enhance their market position. Software-as-a-service (SaaS) represents a software distribution framework where applications are hosted by a third-party provider and made available to users over the Internet. For instance, in December 2023, Merck & Co. Inc., a US-based science and technology company, launched AIDDISON. This platform proposes the most effective methods for synthesizing specific medications. This novel approach could lead to significant cost reductions in the drug discovery process and substantially improve the success rate of bringing new treatments to patients. By connecting virtual molecular design with real-world manufacturability, the platform increases the likelihood of delivering innovative therapies to patients by extracting hidden insights from large datasets. To expedite the medication development process, this advanced AI system integrates computer-aided drug design, machine learning, and generative AI.
Which Organizations Are Involved In The RNA Targeting Small Molecule Drug Discovery Market?
Major companies operating in the rna targeting small molecule drug discovery market are F. Hoffmann-La Roche Ltd, Novartis AG, Bristol-Myers Squibb Company, Moderna Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics, Arbutus Biopharma Corporation, Arbutus Biopharma Corporation
Access The Complete RNA Targeting Small Molecule Drug Discovery Market Report:
Which Region Leads The RNA Targeting Small Molecule Drug Discovery Market By Size?
North America was the largest region in the RNA-targeting small molecule drug discovery market in 2025. The regions covered in the rna targeting small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access RNA Targeting Small Molecule Drug Discovery Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12480&type=smp
Browse Through More Reports Similar to the Global RNA Targeting Small Molecule Drug Discovery Market 2026, By The Business Research Company
Rna Targeting Small Molecule Drug Discovery Market Report 2026
Rna Targeting Small Molecules Therapeutics Market Report 2026
Small Molecule Drug Discovery Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model